| Literature DB >> 31501119 |
Gwen S Fernandes1, Sanjay M Parekh1, Jonathan Moses1, Colin W Fuller2, Brigitte Scammell1, Mark Edward Batt1, Weiya Zhang3, Michael Doherty1.
Abstract
OBJECTIVES: To determine the prevalence of depressive symptoms and general health of male ex-professional footballers compared with general population controls.Entities:
Keywords: anxiety; cardiovascular health; depressive symptoms; epidemiology; pain; professional football; sleep
Mesh:
Year: 2019 PMID: 31501119 PMCID: PMC6738669 DOI: 10.1136/bmjopen-2019-030056
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Selection of ex-footballer and general population controls.
Characteristics of footballer and control populations
| Footballers, n=572 | Controls, n=500 | P value | |
| Age (years), mean (SD) | 60.11 (10.77) | 64.26 (9.37) | <0.001 |
| BMI (kg/m2), mean (SD) | 27.13 (3.40) | 27.29 (4.48) | 0.51 |
| HADS Anxiety Score | 70 (12.01) | 50 (10.29) | 0.34 |
| HADS Depression Score >11, n (%) | 33 (5.66) | 28 (5.76) | 0.94 |
| SF Physical Component Score, mean (SD) | 45.33 (10.32) | 77.60 (8.35) | <0.001 |
| SF Mental Component Score, mean (SD) | 48.09 (7.47) | 71.87 (6.64) | <0.001 |
| Optimal sleep (7–8 hours per night), n (%) | 369 (64.51) | 275 (56.70) | 0.01 |
| Sleep Problem Index (SIP) in highest tertile, n (%) | 186 (33.04) | 131 (26.90) | 0.03 |
| Positive mood, mean (SD) | 34.75 (8.05) | 34.97 (6.86) | 0.63 |
| Negative mood, mean (SD) | 16.5 (6.72) | 14.22 (4.95) | <0.001 |
| Indices of Multiple Deprivation in the lowest and highest quintile, n (%) | 17 (3.51) | 84 (17.28) | <0.001 |
| 205 (42.27) | 199 (40.95) | 0.18 |
BMI, body mass index; HADS, Hospital Anxiety and Depression Scale; SF, Short Form.
Comparison of self-reported comorbidities, pain and medication in the ex-footballers compared with the general population controls
| Footballers, | Controls, | P value | Adjusted relative risk (95% CI) (for age and BMI) | |
| Comorbidities* | 178 (30.58) | 260 (52.31) | <0.001 | 0.74 (0.63 to 0.85)† |
| Comorbidities (by Charlson Comorbidity Index weighting, mean (SD)), n(%)‡ | 0.44 (0.80) | 0.75 (0.98) | <0.001 | 0.71 (0.6–0.85)† |
| Diabetes, n (%) | 22 (3.77) | 57 (11.47) | <0.001 | 0.39 (0.24 to 0.63)† |
| Cancer, n (%) | 40 (6.86) | 50 (8.58) | 0.07 | 0.88 (0.59 to 1.30) |
| Heart attacks, n (%) | 18 (3.08) | 47 (9.46) | <0.001 | 0.43 (0.26 to 0.73)† |
| Hypertension, n (%) | 134 (22.98) | 169 (34.00) | <0.001 | 0.79 (0.65 to 0.96)† |
| Fibromyalgia, n (%) | 3 (0.51) | 1 (0.20) | 0.39 | 3.08 (0.31 to 31.02) |
| Any body pain, n (%) | 454 (78.14) | 330 (71.90) | 0.02 | 1.09 (1.00 to 1.17)§ |
| ACR criteria widespread body pain (no knee pain), n (%) | 48 (8.40) | 23 (4.60) | 0.01 | 1.88 (1.15 to 3.09)§ |
| Total regions with pain, mean (SD) | 3.13 (3.29) | 3.44 (3.05) | 0.14 | 0.91 (0.79 to 1.05) |
| Back pain, n (%) | 176 (30.18) | 146 (29.38) | 0.57 | 1.00 (0.76 to 1.32) |
| Knee pain, n (%) | 337 (57.80) | 193 (38.83) | <0.001 | 1.47 (1.29 to 1.69)§ |
| Pain medication use, n (%) | 240 (41.17) | 165 (33.20) | 0.007 | 1.54 (1.26 to 1.89)§ |
| Opioids, n (%) | 23 (4.03) | 32 (6.40) | 0.07 | 0.64 (0.37 to 1.10) |
| NSAIDS, n (%) | 49 (8.58) | 21 (4.20) | 0.004 | 1.94 (1.19 to 3.20)§ |
| OTC analgesics, n (%) | 137 (23.99) | 70 (14.00) | <0.001 | 1.86 (1.44 to 2.43)§ |
| Other medications, n (%)¶ | 18 (3.15) | 31 (6.20) | 0.01 | 0.50 (0.28–0.94)† |
*Diabetes, hypertension, myocardial infarction, cancer and fibromyalgia.
†Protective factors.
‡Includes myocardial infarction, hypertension, diabetes and cancer.
§Risk factors.
¶Other medications with pain-relieving effects.
ACR, American College of Rheumatology; NSAID, non-steroidal anti-inflammatory drug; OTC, over-the-counter.